Clinical Trials on Lymphoma. Non-Hodgkin
Total 21521 results
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
Shanghai Zhongshan HospitalRecruitingLymphoma | Hodgkin Lymphoma | Non-hodgkin LymphomaChina
-
ADC Therapeutics S.A.CompletedHodgkin Lymphoma | Non-Hodgkin LymphomaUnited States, United Kingdom
-
Masonic Cancer Center, University of MinnesotaRecruitingHodgkin Lymphoma | Non-Hodgkin LymphomaUnited States
-
Burzynski Research InstituteTerminatedNon-hodgkins LymphomaUnited States
-
Burzynski Research InstituteTerminatedNon-hodgkins LymphomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...GlaxoSmithKline; NovartisTerminatedChronic Lymphocytic Leukemia | B-Cell Non-Hodgkin's LymphomaUnited States
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | B-Cell Non-Hodgkin Lymphomas(NHL)China
-
Gilead SciencesCompleted
-
Gilead SciencesTerminated
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Chronic Lymphocytic LeukemiaUnited States
-
Gilead SciencesCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaUnited States
-
Institut fuer anwendungsorientierte Forschung und...CompletedPrimary Non-Hodgkin-Lymphoma | Refractory Non-Hodgkin-Lymphoma | CD20+ Aggressive Non-Hodgkin's LymphomaGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
University of Wisconsin, MadisonGenentech, Inc.TerminatedMantle Cell Lymphoma | Non Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
University of ChicagoRecruitingLymphoma | Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
Sichuan UniversityUnknownHodgkin Lymphoma | Non-hodgkin Lymphoma
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Poland
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
CARsgen Therapeutics Co., Ltd.RenJi Hospital; First Affiliated Hospital of Zhejiang UniversityCompletedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-cell Non-Hodgkin LymphomaChina
-
CytokineticsCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States, Russian Federation
-
Brian HillRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaChina
-
Acibadem UniversityThe Scientific and Technological Research Council of Turkey; Acıbadem Labcell; Acıbadem Atunizade HospitalUnknownStudy of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL (ISIKOK-19)Acute Lymphoblastic Leukemia | Non Hodgkin LymphomaTurkey
-
Affimed GmbHTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Czechia, Germany, Poland
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaChina
-
Joseph TuscanoSpectrum Pharmaceuticals, IncActive, not recruitingRelapsed Non Hodgkin Lymphoma | Refractory Non Hodgkin LymphomaUnited States
-
GC Cell CorporationUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
Loyola UniversityCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
Chinese PLA General HospitalShenzhen University General Hospital; Shenzhen UniversityUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaChina
-
SIRPant Immunotherapeutics, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
La Raza Medical CenterCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaMexico
-
Ronald LevyPfizerCompletedLymphoma | Lymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Follicular / Indolent B-CellUnited States
-
Gilead SciencesOno Pharmaceutical Co. LtdCompletedChronic Lymphocytic Leukaemia | Non Hodgkins LymphomaUnited Kingdom, France
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumors | B-cell Non-Hodgkin LymphomasUnited States
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
Cellect BiotechnologyUnknownAcute Lymphoblastic Leukemia (ALL) | Hodgkin Lymphoma, Adult | Acute Myelogenous Leukemia (AML) | Non Hodgkin Lymphoma (NHL)Israel
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Relapsed Adult ALL | Relapsed CLL | Refractory B-Cell Small Lymphocytic LymphomaUnited States
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
Molecular Templates, Inc.Terminated
-
Peking UniversityShanghai Mingju Biotechnology Co., Ltd.Unknown
-
University Hospital, BrestCompletedDiagnostic Imaging | Relapsed Non Hodgkin Lymphoma | Relapsed Hodgkin's Disease, Adult | Malignant Lymphoma
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan HospitalRecruitingB-cell Non-Hodgkin's LymphomaChina
-
Nanjing IASO Biotherapeutics Co.,LtdNot yet recruitingB-cell Non-Hodgkin's Lymphoma
-
Kyowa Kirin Co., Ltd.Active, not recruitingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Indolent B-cell Non-Hodgkin's LymphomaJapan
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Worldwide Clinical TrialsSuspendedB-cell Non-Hodgkin's LymphomaUnited States
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
SandozNovartis PharmaceuticalsCompletedIndolent B-cell Non-Hodgkin's LymphomaJapan
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland